Ikarian Capital’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Hold
2025
Q1
Hold
2024
Q4
Hold
2024
Q3
Hold
2022
Q2
Sell
2022
Q1
$837K Buy
2021
Q4
$1.16M Sell
2021
Q3
$3.67M Buy
2021
Q2
$267K Hold
2021
Q1
$307K Buy